Shares of Inspire Medical Systems (INSP) surged 19.7% after reports indicated that the Centers for Medicare & Medicaid Services (CMS) plans to assign specific C-codes for the Inspire V device in the April 2026 Integrated Outpatient Code Editor (IOCE) update. This regulatory win, highlighted by KeyBanc analysts, addresses previous reimbursement uncertainties and is expected to simplify billing and lead to more predictable payments for the company’s sleep apnea treatment. The news helped restore investor confidence after earlier revenue guidance reductions due to “coding headwinds.”
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Inspire Medical Systems (INSP) Stock Trades Up, Here Is Why
Shares of Inspire Medical Systems (INSP) surged 19.7% after reports indicated that the Centers for Medicare & Medicaid Services (CMS) plans to assign specific C-codes for the Inspire V device in the April 2026 Integrated Outpatient Code Editor (IOCE) update. This regulatory win, highlighted by KeyBanc analysts, addresses previous reimbursement uncertainties and is expected to simplify billing and lead to more predictable payments for the company’s sleep apnea treatment. The news helped restore investor confidence after earlier revenue guidance reductions due to “coding headwinds.”